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ABSTRACT
We report the current situation regarding the COVID-19 pandemic with particular regard to seafarers and 
with the indications drawn up by the Centro Internazionale Radio Medico (C.I.R.M.) in this regard.
(Int Marit Health 2020; 71, 3: 191–194)




Coronaviruses are a large family of viruses, which in-
clude 4 genera: a and b infect mammals while g and d 
infect birds. In humans, several coronaviruses are known to 
cause respiratory infections ranging from the common cold 
to more severe diseases, such as severe acute respiratory 
syndrome (SARS) and Middle East respiratory syndrome 
(MERS) [1]. The most recently discovered coronavirus is 
SARS-CoV-2 which causes the coronavirus disease named 
COVID-19. This new virus and resulting disease were un-
known before the outbreak that began in Wuhan, China, in 
November–December 2019. SARS-CoV-2 and SARS-CoV 
share approximately 80% of genomic material.
This report takes stock of the situation approximately 
3 months after it was declared a pandemic by the World Health 
Organization (WHO; March 11, 2020) [2], and reports the 
position of the Centro Internazionale Radio Medico (C.I.R.M., 
International Radio Medical Centre, the Italian Telemedical 
Advice Service) with regard to this topic. The C.I.R.M. was 
established in 1935 to provide medical care via telecom-
munication systems to seafarers of all nationalities, sailing 
across the seas, aboard vessels without a doctor on board.
The ongoing COVID-19 outbreak probably started in 
November–December 2019. Wuhan is the capital of the 
Hubei Province, located at the confluence of the Changjiang 
River and the Hanshui River. Today Wuhan is considered 
the political, economic, financial, commercial, cultural and 
educational centre of central China. It is a major transpor-
tation hub, with dozens of railways, roads and expressways 
passing through the city and connecting to other major 
cities. Wuhan Tianhe International Airport, which opened 
in April 1995 in order to replace the previous Hankou 
Wangjiadun and Nanhu airports, thus becoming Wuhan’s 
major airport, is one of the busiest airports in central 
China. Wuhan is also a major hub for maritime transport 
in central China. The port of Wuhan hosts services for the 
local population and for shipping enterprises. 
The John Hopkins University database, in the sit-
uation report of June 28, 2020, stated that there are 
9,953,083 confirmed cases with 498,217 deaths [2]. There 
are 240,136 confirmed cases in Italy with 34,716 deaths, 
with a lethality rate of approximately 14% [3]. 
The signs and symptoms of 2019-nCoV include fever, 
cough, respiratory problems and pneumonia. Human-to-hu-
man transmission may occur during the incubation period 
(before symptoms appear), and the average time from 
infection until the onset of the disease is approximately 
7 days, with a maximum incubation period of approximately 
14 days. WHO has defined suspect, probable and con-
firmed cases, as well as contacts, as indicated below [4].
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SHORT  COMMUNICAT ION
SUSPECT CASE
 — A patient with acute respiratory illness (fever and at 
least one sign/symptom of respiratory disease, e.g., 
cough, shortness of breath), AND a history of travel to 
or residence in a location reporting community trans-
mission of COVID-19 disease during the 14 days prior 
to symptom onset; OR
 — A patient with any acute respiratory illness AND hav-
ing been in contact with a confirmed or probable 
COVID-19 case (see definition of contact) in the last 
14 days prior to symptom onset; OR
 — A patient with severe acute respiratory illness (fever and 
at least one sign/symptom of respiratory disease, e.g., 
cough, shortness of breath; AND requiring hospitalisa-
tion) AND in the absence of an alternative diagnosis that 
fully explains the clinical presentation.
PROBABLE CASE 
 — A suspect case for whom testing for the COVID-19 virus 
is inconclusive; OR
 — A suspect case for whom testing could not be performed 
for any reason.
CONFIRMED CASE 
A person with laboratory confirmation of COVID-19 in-
fection, irrespective of clinical signs and symptoms. See 




A contact is a person who experienced any one of the 
following exposures during the 2 days before and the 14 days 
after the onset of symptoms of a probable or confirmed case: 
 — face-to-face contact with a probable or confirmed case 
within 1 m and for more than 15 min;
 — direct physical contact with a probable or confirmed case;
 — direct care for a patient with probable or confirmed 
COVID-19 disease without using proper personal pro-
tective equipment;
 — other situations as indicated by local risk assessments. 
Note: For confirmed asymptomatic cases, the period 
of contact is measured as the 2 days before through the 
14 days after the date on which the sample was taken which 
led to confirmation. 
A recent review of 22 studies by Krampf et al. [5], on 
SARS, MERS and HcoV (alphacoronavirus) syndromes, all 
variants of coronavirus, has highlighted the persistence of 
these viruses on inanimate surfaces for up to 9 days, and 
that the use of ethanol, sodium hypochlorite and hydrogen 
peroxide inactivates the viruses within one minute. In the 
recent history of public hygiene we have seen the danger-
ousness of the coronavirus family variants, namely the SARS 
and MERS viruses. The main mode of transmission of these 
pathologies was also airborne, with COVID-19 having similar 
animal reservoirs as SARS [1]; while the main animal reser-
voir for MERS seems to have been the camel [1]. In 2003 the 
fatality rate of SARS, which also originated in China, was 
approximately 10%, while in 2012 the fatality rate of MERS 
was an average of approximately 35% (WHO data). The initial 
clinical information on COVID-19 is summarised in Table 1, 
which reports the data of two initial patient cohorts from 
two hospitals in Wuhan [6, 7] and subsequently one cohort.
The initial data showed that almost all patients had 
a fever (98% of cases) and radiographically visible pneu-
monia (100% of cases). A cough was present in 60–76% 
of cases and dyspnoea in 30–55% of cases. The median 
time between the onset of symptoms and hospitalisation 
was 7 days for both of the patient cohorts reported in Ta-
ble 1. If acute respiratory distress syndrome developed, 
the median time to onset was 8–9 days from the start of 
symptoms. This data has been substantially confirmed 
Table 1. Patient data from two hospitals in Wuhan (two initial patient cohorts)
Huang C et al. [6]
(Jin Yintan Hospital, Wuhan):
41 patients (January 2–24, 2020)
Wang D et al. [7]
(Zhongnan Hospital, Wuhan):
138 patients (January 1–28, 2020)
Men 73% 54.3%
Mean age 49 years 56 years
Main symptoms Fever (98%), cough (76%), dyspnoea (55%),  
lymphopenia (63%)




Intensive Care Unit 32% 26.1%
Lethality 15% 4.3%
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with a meta-analysis by Li et al. [8] with 1994 patients origi-
nating from 10 scientific works selected. The lethality of this 
meta-analysis was 7%. The largest cause for the transmission 
and the wide spread of COVID-19 within the province of Hubei 
was local transportation, while the spread to other countries 
was through airplanes. Maritime transport could have, or has, 
played a role in the spreading of COVID-19, but given the slow-
er speed and the confined spaces used, COVID-19 spreads 
less effectively than with air transport.
The first American case of COVID-19 was reported on 
March 5, 2020, and in addition to the symptoms sum-
marised in Table 1, the case also presented with abdominal 
pain and loose stools, testing positive for COVID-19 [9]. On 
June 28, 2020 the confirmed cases of SARS-CoV-2 in United 
States are 2,510,092 with 125,539 deaths [3]. 
The term quarantine, or forced confinement, is well-
known in the maritime sector and actually originates from 
the word “forty” in Italian, which refers to the forty day 
period during which the Venetian government in the 16th 
century forbade any ships from approaching the port of 
Venice in order to avoid contaminating the city with the 
black plague. Sikorska [10] highlights that the lack of an 
effective treatment or a vaccine renders quarantine as the 
only effective protection.
In the maritime sector there are two types of shipping 
that must be underline. Cruise ships carry a large number 
of people, travelling to multiple destinations and providing 
a high number of available services (including healthcare 
ones). Cargo ships, instead, transport any type of goods 
(hydrocarbons, metals, various chemicals, etc.) and the 
crew does not exceed 30 members, without any medi-
cal services and with an average 3–6 months period of 
stay on board. In order to be able to continue supplying 
raw materials (hydrocarbons, chemical substances, etc.) 
even in endemic areas, this type of commercial maritime 
transport must continue, with the foresight that the per-
sonnel on board cannot disembark and no personnel can 
be replaced. Reducing all contact between the ship and 
external personnel to a minimum is essential, and with 
these dealings a safe distance must be kept, and protec-
tive gloves and masks must be used as specified by the 
guidelines issued by the United States Centre for Disease 
Control and Prevention [11]. According to these guidelines, 
the safety distance on board should be approximately 
6 feet (approx. 1.8 m).
The use of N95 filtering face masks is only recommend-
ed for those who are directly assisting suspect/probable 
or confirmed cases, and this assistance should always be 
provided by the same people, who will also wear disposable 
goggles as protection and medical gloves. For individuals 
experiencing fever, cough or dyspnoea, only the use of 
a surgical mask is recommended.
The frequent washing of hands for at least 20 s, with 
water and soap or a 60–95% alcohol solution, is prescribed 
to everyone.
In general, the medical devices on these ships are limit-
ed to only a sphygmomanometer and a thermometer, thus 
lacking the ability of evaluating fundamental vital signs 
such as blood oxygen saturation or performing an electro-
cardiogram test.
In this respect, the C.I.R.M. has always insisted on diffus-
ing telemedicine stations on merchant ships, which would 
render it possible to quickly assess the conditions of sea-
farers on board, even remotely. 
The issues encountered aboard these types of ships 
during this COVID-19 epidemic are:
 — discerning between a common flu and a form of 
COVID-19;
 — on-board isolation methods;
 — any method of evacuation (MEDical EVACuation).
In the event of a suspect/probable case of COVID-19, 
knowing the history, movements and origin of the index 
case(s) is absolutely necessary. With this information and 
with the epidemiological data that is being collected, the 
case can be categorised in the appropriate risk range. It 
is essential to follow the clinical progress of the patient(s) 
who, if suspected to have contracted COVID-19, should 
be isolated in the infirmary, which should be equipped 
with one or two hospital beds and medical oxygen, and 
where the use of the toilet is reserved to the patient(s) 
and can be easily cleaned with a sodium hypochlorite 
solution. 
If the fever (≥ 38°C) and respiratory symptoms re-
solve within a few days and the risk of having been in-
fected is low, clearly, chances are the person did not con-
tract COVID-19. Nevertheless, the lingering issue is that 
COVID-19 can also manifest itself in milder forms, similar 
to the flu, and diagnostic tests for COVID-19 cannot be 
conducted in all the ports. In the event of a suspected 
COVID-19 infection, the staff must obviously undergo quar-
antine and therefore cannot leave the ship that has docked 
at the port, to load and unload goods.
In ports of entry, the ship with suspect cases should 
be moored and the parties should disembark and undergo 
diagnostic tests in local equipped healthcare facilities, if 
possible. If such tests are not available, the index case will 
still have to undergo radiological diagnostics in order to 
check if viral pneumonia is present. If the diagnostic tests 
for the index case are not available, the personnel on board 
should remain in isolation for 14 days, starting from when 
the symptoms of the index case began. Frequent hand 
washing is a requirement for all quarantined personnel. As 
of today, potential COVID-19 vaccines are still in the testing 
phase, and with time being of the essence, many companies 
www.intmarhealth.pl 193
Paolo Sossai et al., COVID-19 quide for seafarers
have announced that they have been developing potential 
vaccines to curb further spread of the virus.
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